Vasista Adiga

Vasista Adiga

Auto-generated profile, based on publicly available information

Vasista Adiga

Laboratory of Immunology of HIV-TB co-infection, Centre for Infectious Disease Research, Indian Institute of Science, Bangalore, India

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
RMRicha Mishra
Richa Mishra
SKSakshi Kohli
Sakshi Kohli
NMNitish Malhotra
Nitish Malhotra
PBParijat Bandyopadhyay
Parijat Bandyopadhyay
MMMansi Mehta
Mansi Mehta
ASAmit Singh
Amit Singh
Chloroquine resets the redox physiology of Mycobacterium tuberculosis to potentiate the efficacy of antibiotics in vivo.

19 December 2019 in JCI Insight
Verified
Journal Article
Open access
PDF file
SRSrabanti Rakshit
Srabanti Rakshit
AAAsma Ahmed
Asma Ahmed
VAVasista Adiga
Vasista Adiga
BSBharath K. Sundararaj
Bharath K. Sundararaj
PSPravat Nalini Sahoo
Pravat Nalini Sahoo
AVAnnapurna Vyakarnam
Annapurna Vyakarnam
BACKGROUND: Bacille Calmette-Guérin (BCG) vaccine is protective against Tuberculosis (TB) in children, but its efficacy wanes with age. Consequently, determining if BCG revaccination augments anti-TB immunity in young adults in TB endemic regions is vital. METHODS: Two hundred healthy adults, BCG vaccinated at birth, were tested for their IFN-γ release assay (IGRA) status. Of these, 28 IGRA + and 30 IGRA – were BCG revaccinated, and 24 IGRA + and 23 IGRA – subjects served as unvaccinated controls. T and innate cell responses to mycobacterial antigens were analyzed by 14-color flow cytometry over 34 weeks. RESULTS: IFN-γ and/or IL-2 Ag85A- and BCG-specific CD4 + and CD8 + T cell responses were boosted by revacciantion at 4 and 34 weeks, respectively, and were > 2-fold higher in IGRA + compared with IGRA – vaccinees. Polyfunctional Ag85A, BCG, and mycobacterium tuberculosis (Mtb) latency Ag–specific (LTAg-specific) CD4 + T cells expressing up to 8 cytokines were also significantly enhanced in both IGRA + and IGRA – vaccinees relative to unvaccinated controls, most markedly in IGRA + vaccinees. A focused analysis of Th17 responses revealed expansion of Ag85A-, BCG-, and LTAg-specific total IL-17A + ,IL-17F + ,IL-22 + , and IL-10 + CD4 + T cell effectors in both IGRA + and IGRA – subjects. Also, innate IFN-γ + NK/γδ/NKT cell responses were higher in both IGRA + and IGRA – vaccinees compared with controls. This is the first evidence to our knowledge that BCG revaccination significantly boosts antimycobacterial Th1/Th17 responses in IGRA + and IGRA – subjects. CONCLUSION: These data show that BCG revaccination is immunogenic in IGRA – and IGRA + subjects, implying that Mtb preinfection in IGRA + subjects does not impact immunogenicity. This has implications for public health and vaccine development strategies. FUNDING: This work was funded principally by DBT-NIH (BT/MB/Indo-US/HIPC/2013).

19 September 2018 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
AAAsma Ahmed
Asma Ahmed
VAVasista Adiga
Vasista Adiga
SNSoumya Nayak
Soumya Nayak
JKJ. Anto Jesuraj Uday Kumar
J. Anto Jesuraj Uday Kumar
CDChirag Dhar
Chirag Dhar
AVAnnapurna Vyakarnam
Annapurna Vyakarnam
Chronic T cell activation is a hallmark of pulmonary tuberculosis (PTB). The mechanisms underpinning this important phenomenon are however, poorly elucidated, though known to rely on control of T effector cells (Teff) by regulatory T cells (Treg). Our studies show that circulating natural Treg cells in adults with PTB preserve their suppressive potential but Teff cells from such subjects are resistant to Treg-mediated suppression. We found this to be due to expansion of an activated Teff subset identified by Human Leukocyte Antigen (HLA)-DR expression. Sensitivity to suppression was restored to control levels by depletion of this subset. Comparative transcriptome analysis of Teff cells that contain HLA-DR+ cells versus the fraction depleted of this population identified putative resistance mechanisms linked to IFNG, IL17A, IL22, PD-L1 and β-chemokines CCL3L3, CCL4 expression. Antibody blocking experiments confirmed HLA-DR+ Teff cells, but not the fraction depleted of HLA-DR+ effectors, to be resistant to Treg suppression mediated via CCR5 and PD-L1 associated pathways. In the presence of HLA-DR+ Teff cells, activation of NFκB downstream of CCR5 and PD-L1 was perturbed. In addition, HLA-DR+ Teff cells expressed significantly higher levels of Th1/Th17 cytokines that may regulate Treg function through a reciprocal counter-balancing relationship. Taken together, our study provides novel insight on how activated HLA-DR+CD4+ T cells may contribute to disease associated inflammation by compromising Treg-mediated suppression in PTB. An important marker of progression to PTB following Mycobacterium tuberculosis (Mtb) infection in humans is elevated frequencies of HLA-DR+CD4+ T cells, reflecting chronic T cell activation. However, the mechanisms by which activated HLA-DR+CD4+ T cells contribute to disease process is not known. We show that CD25- HLA-DR+CD4+ memory Teff from PTB patients are resistant to suppression mediated by Treg cells. An unbiased transcriptome analysis identified several key pathways that contribute to this resistance. Specifically, presence of HLA-DR+CD4+ T cells renders the effector population resistant to CCR5 and PD-L1 mediated suppression by Treg cells. In addition, the HLA-DR+CD4+ memory Teff cells express elevated levels of Th1/Th17 cytokines known to counter-regulate and dampen Treg suppression. These findings provide fresh insight to disease process in TB and identify HLA-DR+ Teff resistant to Treg suppression as a potential functional marker of disease.

1 February 2018 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
SYShikha Yadav
Shikha Yadav
SPSanmoy Pathak
Sanmoy Pathak
MSMohsen Sarikhani
Mohsen Sarikhani
SMShamik Majumdar
Shamik Majumdar
SRSemanti Ray
Semanti Ray
DNDipankar Nandi
Dipankar Nandi

20 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SRSrabanti Rakshit
Srabanti Rakshit
VAVasista Adiga
Vasista Adiga
SNSoumya Nayak
Soumya Nayak
PSPravat Nalini Sahoo
Pravat Nalini Sahoo
PSPrabhat Kumar Sharma
Prabhat Kumar Sharma
AVAnnapurna Vyakarnam
Annapurna Vyakarnam
The functional heterogeneity of T cell responses to diverse antigens expressed at different stages of Mycobacterium tuberculosis (Mtb) infection, in particular early secreted versus dormancy related latency antigens expressed later, that distinguish subjects with latent (LTBI), pulmonary (PTB) or extrapulmonary (EPTB) tuberculosis remains unclear. Here we show blood central memory CD4 T-cell responses specific to Mtb dormancy related (DosR) latency, but not classical immunodominant secretory antigens, to clearly differentiate LTBI from EPTB and PTB. The polyfunctionality score integrating up to 31 DosR-specific CD4 T-cell functional profiles was significantly higher in LTBI than EPTB or PTB subjects. Further analysis of 256 DosR-specific T-cell functional profiles identified regulatory IL10 + Th17 cells (IL10+IL17A+IL17F+IL22+) to be significantly enriched in LTBI; in contrast to pro-inflammatory Th17 cells (IFNγ+IL17A+/IL10−) in the blood and lung of EPTB and PTB subjects respectively. A blood polyfunctional, Mtb DosR latency antigen specific, regulatory, central memory response is therefore a novel functional component of T-cell immunity in latent TB and potential correlate of protection.

16 January 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SMShamik Majumdar
Shamik Majumdar
MDMukta Deobagkar-Lele
Mukta Deobagkar-Lele
VAVasista Adiga
Vasista Adiga
ARAbinaya Raghavan
Abinaya Raghavan
NWNitin Wadhwa
Nitin Wadhwa
DNDipankar Nandi
Dipankar Nandi
The thymus is known to atrophy during infections; however, a systematic study of changes in thymocyte subpopulations has not been performed. This aspect was investigated, using multi-color flow cytometry, during oral infection of mice withSalmonellaTyphimurium (S. Typhimurium). The major highlights are: First, a block in the developmental pathway of CD4−CD8−double negative (DN) thymocytes is observed. Second, CD4+CD8+double positive (DP) thymocytes, mainly in the DP1 (CD5loCD3lo) and DP2 (CD5hiCD3int), but not DP3 (CD5intCD3hi), subsets are reduced. Third, single positive (SP) thymocytes are more resistant to depletion but their maturation is delayed, leading to accumulation of CD24hiCD3hiSP. Kinetic studies during infection demonstrated differences in sensitivity of thymic subpopulations: Immature single positive (ISP) > DP1, DP2 > DN3, DN4 > DN2 > CD4+ > CD8+. Upon infection, glucocorticoids (GC), inflammatory cytokines, e.g. Ifnγ, etc are induced, which enhance thymocyte death. Treatment with RU486, the GC receptor antagonist, increases the survival of most thymic subsets during infection. Studies withIfnγ−/−mice demonstrated that endogenous Ifnγ produced during infection enhances the depletion of DN2-DN4 subsets, promotes the accumulation of DP3 and delays the maturation of SP thymocytes. The implications of these observations on host cellular responses during infections are discussed.